Skip to main content
. 2019 Dec 19;13:4331–4340. doi: 10.2147/DDDT.S225613

Figure 5.

Figure 5

Scores of DAS28 and HAQ were evaluated after twice of UC-MSCs treatment. (A) DAS28 score was evaluated; (B) HAQ score was evaluated. Pre-treatment versus after the first or second treatment; *** represents P < 0.001, 1-year posttreatment versus 3-year posttreatment; * represents P < 0.05 (n = 64).